“People want covid-19 to be in the rearview mirror,” one nursing home official says. Faced with a slow rollout of the updated covid vaccines, and without state mandates for workers to get vaccinated, most skilled nursing facilities are relying on persuasion to boost vaccination rates among staff and residents.
Americans think losing their eyesight would be one of the worst possible health outcomes, yet millions lack a fundamental understanding of eye health.
Beneficiaries in five states described what happened when they received demands to return overpayments that reached up to tens of thousands of dollars or more.
The Biden administration says a recently proposed minimum staffing standard would help ensure quality care, but nursing home leaders predict many rural facilities would struggle to meet it.
As covid-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters — and not only for those at highest risk of serious disease. Here are seven things you need to know.
Congress returns from its summer recess with a long list of tasks and only a few work days to get them done. On top of the annual spending bills needed to keep the government operating, on the list are bills to renew the global HIV/AIDS program, PEPFAR, and the community health centers program. Meanwhile, over the recess, the Biden administration released the names of the first 10 drugs selected for the Medicare price negotiation program.
The proposal would require major hiring at the most sparsely-staffed homes. But the proposal is already badly received by the nursing home industry which claims it can’t boost wages enough to attract workers.
Research commissioned by the Centers for Medicare & Medicaid Services analyzed only staffing levels lower than the current federal standard. Patient advocates have been pushing for more staff to improve care.
The federal government is proposing having Medicare pay professionals to train family caregivers how to perform tasks like bathing and dressing their loved ones, and properly use medical equipment.
Clinics serving Alzheimer’s patients are working out the details of who will get treated with the new drug Leqembi. It won’t be for everyone with memory-loss symptoms.
